Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03088462 · ClinicalTrials.gov registry record · NA
LiveWell: A Mobile Intervention for Bipolar Disorder
A NA study of Bipolar Disorder and Bipolar I Disorder, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 205
- Enrollment target
- 2
- Study locations
NCT03088462: Completed NA study of Bipolar Disorder and Bipolar I Disorder, sponsored by Northwestern University.
NCT03088462 is a NA study of Bipolar Disorder and Bipolar I Disorder that has completed, run by Northwestern University. The registered enrollment target is 205 participants, below the 331-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (38% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03088462, a NA study of Bipolar Disorder and Bipolar I Disorder, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 205 participants
- Enrollment target
- 2
- Study locations
Study Summary
LiveWell is a study evaluating the use of smartphones to better understand and improve the treatment of bipolar disorder. Our goal is to increase access to psychosocial interventions and improve their effectiveness in reducing symptoms and preventing mood episodes.
Primary Outcome
Semi-structured interview designed to assess clinical status allowing determination of time to relapse (onset of a mood episode). Clinical Status: episode = depression, mania, hypomania, mixed; continued symptomatic (≥ 3 moderate symptoms without recovery), recovering (≤ 2 moderate symptoms, ≤ 8 weeks), prodromal (≥ 3 moderate symptoms after recovery); recovered (≤ 2 moderate symptoms, ≥ 8 weeks).
Conditions Studied
Interventions
- BEHAVIORAL Psychosocial treatment
- OTHER Psychiatric management
- BEHAVIORAL LiveWell Program
Study Locations (2)
Illinois
- Northwestern University - Chicago
Minnesota
- HealthPartners Institute - Bloomington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2017-03-20 |
| Est. Completion | 2021-04-10 |
| Phase | NA |
What the finished NCT03088462 record still lists
NCT03088462 is an interventional study that assigns participants to a tested intervention. The registered 205 participants enrollment target is mid-sized for trials with a published cap, below the 331-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (38% lower).
The record links to 2 conditions, with Bipolar Disorder appearing as the primary indexed condition, and to 3 interventions - of which Psychosocial treatment is the first listed.
NCT03088462 reports a single indexed study location in Illinois, Minnesota.
Frequently Asked Questions
What is clinical trial NCT03088462 about?
NCT03088462 is a clinical study titled "LiveWell: A Mobile Intervention for Bipolar Disorder". LiveWell is a study evaluating the use of smartphones to better understand and improve the treatment of bipolar disorder. Our goal is to increase access to psychosocial interventions and improve their effectiveness in reducing symptoms and preventing mood episodes.
What is the current status of trial NCT03088462?
This trial is currently completed. It is a NA study. The enrollment target is 205 participants. The study started on 2017-03-20. Estimated completion is 2021-04-10.
What conditions does trial NCT03088462 study?
This clinical trial studies the following conditions: Bipolar Disorder, Bipolar I Disorder.
What interventions are being tested in trial NCT03088462?
The interventions under investigation include: Psychosocial treatment (BEHAVIORAL), Psychiatric management (OTHER), LiveWell Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03088462?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03088462 being conducted?
This trial has 2 study locations across Illinois, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03088462's enrollment target sits among peer trials
205 34th of 162 higher than 129 of 162 other Bipolar Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bipolar Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Intermittent Theta Burst Stimulation (iTBS) for Emotion Regulation in Bipolar Disorder
RECRUITING · NA
-
Healthy Lifestyles in Bipolar Disorder: Bay Area Study
RECRUITING · NA
-
A Future Thinking Intervention for Comorbid Tobacco Use Disorder and Bipolar Disorder
RECRUITING · NA
-
Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03457493 · 205 participants · Phase 1
The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy
- NCT05134857 · 205 participants · Phase 2
The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study
- NCT05181891 · 205 participants · Phase 2
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
- NCT05283811 · 205 participants · NA
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI